ghk cu subcutaneous GHK-CU ghk-cu injectable dosage subcutaneous typical

For most researchers, 3 mL (10 mg/mL) offers the best balance of precision and comfort

In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group

PubMed laboratory research record [PMID: 6141649] PubMed record related to this compound for laboratory literature review

How It Works 1

Inject 2.5mL (or 250 units) of BAC water into the 5mg Tesamorelin vial